When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA - Report - MDSpire

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA

  • By

  • J. Noll

  • M. Reichert

  • M. Dietrich

  • J. G. Riedel

  • M. Hecker

  • W. Padberg

  • M. A. Weigand

  • A. Hecker

  • March 21, 2022

  • 0 min

Share

Timing of Surgical Interventions Following SARS-CoV-2 Infection: Guideline Overview

Overview

The COVID-19 pandemic has significantly impacted surgical scheduling, with elective surgeries postponed to reduce risks. Recent guidelines from DGC/BDC and DGAI/BDA provide recommendations on optimal timing for surgery after SARS-CoV-2 infection to minimize postoperative complications and mortality.

Background

SARS-CoV-2 infection affects multiple organ systems due to the virus's interaction with ACE2 receptors, leading to a spectrum of disease severity from asymptomatic to critical illness. The pandemic caused delays in elective surgeries, impacting patient outcomes and healthcare resources. Postoperative complications such as infections and thromboembolic events are major concerns, especially in patients with recent or ongoing COVID-19. Understanding the pathophysiology and timing of surgery after infection is crucial for perioperative management.

Data Highlights

According to the Robert-Koch Institute, 1.8% of confirmed SARS-CoV-2 cases in Germany resulted in death as of November 2021. Severe COVID-19 cases have a case-fatality rate of approximately 49%. In the first wave, 80% of cases were mild with a mortality rate of 5.6%, varying by age. Postoperative infections and thromboembolic events remain leading causes of surgical mortality, exacerbated by recent SARS-CoV-2 infection.

Key Findings

  • Elective surgeries were widely postponed during the pandemic to reduce perioperative risks associated with SARS-CoV-2 infection.
  • SARS-CoV-2 binds to ACE2 receptors, widely expressed in lungs, kidneys, GI tract, and heart, causing multisystem involvement.
  • Postoperative complications such as infections and thromboembolic events are increased in patients with recent COVID-19.
  • Long Covid symptoms and systemic inflammation may contribute to prolonged perioperative risk.
  • Guidelines recommend delaying elective surgery for a defined period after SARS-CoV-2 infection to reduce morbidity and mortality.
  • Risk stratification and prophylactic measures are essential to optimize surgical outcomes in patients with prior COVID-19.

Clinical Implications

Clinicians should carefully assess the timing of elective surgeries following SARS-CoV-2 infection, considering the severity of prior COVID-19 and presence of ongoing symptoms. Utilizing risk scores and implementing prophylactic strategies can help mitigate postoperative complications. Awareness of Long Covid and its potential impact on recovery is important for perioperative planning.

Conclusion

Surgical management in the era of COVID-19 requires integration of infection timing and patient risk factors to optimize outcomes. Adhering to updated guidelines ensures safer surgical care for patients with a history of SARS-CoV-2 infection.

References

  1. Robert-Koch Institute 2021 -- COVID-19 Mortality Data in Germany
  2. DGC/BDC and DGAI/BDA Guidelines -- Timing of Surgery Post SARS-CoV-2 Infection

Original Source(s)

Related Content